All News #Library
Rare Diseases
Protagonist & Takeda`s ASCO Presentation on Ph 3 VERIFY Study
01 Jun 2025 //
BUSINESSWIRE
Takeda wagers $300M on Protagonist’s PhIII rare disease drug
01 Feb 2024 //
ENDPTS

Market Place
Sourcing Support